Marham‐Mafasel decrease joint inflammation and IL‐1β gene expression in rheumatoid arthritis animal model
Open Access
- 3 May 2021
- journal article
- research article
- Published by Wiley in Veterinary Medicine and Science
- Vol. 7 (4) , 1417-1425
Abstract
Background: Rheumatoid arthritis (RA) is a systemic chronic disease with synovial membrane, tendon and articular tissue inflammation. Current treatments of RA have many side effects and are quite expensive. Today, new treatments procedures and inexpensive herbal drugs are developed. Marham‐Mafasel is mainly made out of two traditional herbs (Arnebia euchroma and Martricaria chamomilla).Objective: In this study, for the first time, the impact of Marham‐Mafasel on joint inflammation, histopathological changes and IL‐1β gene expression was evaluated in RA animal model.Methods: The RA was induced by a single s.c. injection of 0.1 ml Freund's complete adjuvant into the left hind footpad. In continuous, 15 RA male Wistar rats were used in three groups: I: Control; II: Treatment I (Piroxicam) and III: Treatment II (Marham‐Mafasel). The volume of the hind paw was measured every day from 0 to 19 using water changed volume approach. The inflammation in the joint was evaluated using histopathology assay and gene expression of IL‐1β was evaluated with use of Real‐Time PCR.Results: Hind paw swelling of Marham‐Mafasel at days 10th and 19th was reduced compared with the control group (p < 0.05). There was no statistically difference in histological degrading and changes index in three groups (p ≥ 0.05). Relative expression of IL‐1β in Marham‐Mafasel group was significantly decreased compared with other groups.Conclusion: The co‐administration of M. Chamomile and A. euchroma, called Marham‐Mafasel, decreases IL‐1β gene expression that leads to a reduction in inflammation in rheumatoid arthritis (RA) animal model.Keywords
This publication has 39 references indexed in Scilit:
- Natural Killer Cells and Their Role in Rheumatoid Arthritis: Friend or Foe?The Scientific World Journal, 2012
- Historical Perspective on the Etiology of Rheumatoid ArthritisHand Clinics, 2011
- Rodent Preclinical Models for Developing Novel Antiarthritic Molecules: Comparative Biology and Preferred Methods for Evaluating EfficacyBioMed Research International, 2010
- Chamomile: A herbal medicine of the past with a bright future (Review)Molecular Medicine Reports, 2010
- Mixture of Arnebia euchroma and Matricaria chamomilla (Marhame-Mafasel) for pain relief of osteoarthritis of the knee – a two-treatment, two-period crossover trialArchives of Medical Science, 2010
- Fibroblast‐like synoviocytes: key effector cells in rheumatoid arthritisImmunological Reviews, 2009
- Different properties of ACPA and IgM-RF derived from a large dataset: further evidence of two distinct autoantibody systemsArthritis Research & Therapy, 2009
- The Immunopathogenesis of Rheumatoid ArthritisAnnual Review of Pathology: Mechanisms of Disease, 2009
- Anticancer Effects of HESA-A in Patients With Metastatic Colon CancerIntegrative Cancer Therapies, 2009
- The role of interleukin-1 in the pathogenesis of rheumatoid arthritisRheumatology, 2004